Michael Gibertini, President Clinical Development at INC Research Holdings, Inc. (INCR), sold 401,538 shares at $43.05 ($17.3M) on 2016-06-06, disclosed to the SEC on 2016-06-07.
Open-market sale of $17.3M INCR by President Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.05 | 16,652 | $717K | 4.1% |
| 2 | $43.05 | 26,394 | $1.1M | 6.6% |
| 3 | $43.05 | 16,652 | $717K | 4.1% |
| 4 | $43.05 | 144,682 | $6.2M | 36.0% |
| 5 | $43.05 | 144,682 | $6.2M | 36.0% |
| 6 | $43.19 | 13,751 |
| $594K |
| 3.4% |
| 7 | $43.19 | 13,751 | $594K | 3.4% |
| 8 | $43.76 | 1,100 | $48K | 0.3% |
| 9 | $43.76 | 1,100 | $48K | 0.3% |
| 10 | $43.82 | 877 | $38K | 0.2% |
| 11 | $43.82 | 877 | $38K | 0.2% |
| 12 | $43.83 | 9,034 | $396K | 2.3% |
| 13 | $43.83 | 9,034 | $396K | 2.3% |
| 14 | $43.84 | 1,476 | $65K | 0.4% |
| 15 | $43.84 | 1,476 | $65K | 0.4% |
| Total | $43.11 avg | 401,538 | $17.3M | 100% |
| Filing → |
| INCR | SELL | 2016-02-02 | $365K | — | Filing → |
| INCR | SELL | 2016-01-06 | $421K | — | Filing → |
| INCR | SELL | 2015-12-03 | $419K | — | Filing → |